Antibody response to the 23-valent pneumococcal polysaccharide vaccine after conjugate vaccine in patients with chronic lymphocytic leukemia

The 23-valent pneumococcal polysaccharide vaccine (PPV23) given alone is ineffective in patients with chronic lymphocytic leukemia (CLL) and better antibody response is achieved with pneumococcal conjugate vaccines (PCVs). In this study, we determine whether CLL patients would achieve a significant...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Hum Vaccin Immunother
Main Authors: Lindström, Vesa, Aittoniemi, Janne, Salmenniemi, Urpu, Käyhty, Helena, Huhtala, Heini, Sinisalo, Marjatta
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis 2019
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6930110/
https://ncbi.nlm.nih.gov/pubmed/31216225
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1627160
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki